Annual Current Liabilities
$2.11 M
+$321.00 K+17.97%
31 December 2022
Summary:
Nymox Pharmaceutical annual total current liabilities is currently $2.11 million, with the most recent change of +$321.00 thousand (+17.97%) on 31 December 2022. During the last 3 years, it has risen by +$142.00 thousand (+7.23%).NYMX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$2.37 M
+$267.00 K+12.67%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly total current liabilities is currently $2.37 million, with the most recent change of +$267.00 thousand (+12.67%) on 31 March 2023.NYMX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +7.2% | +30.2% |
| 5 y5 years | +96.2% | +42.7% |
NYMX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -59.4% | -54.3% |
Nymox Pharmaceutical Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $2.37 M(+12.7%) |
| Dec 2022 | $2.11 M(+18.0%) | $2.11 M(-10.6%) |
| Sept 2022 | - | $2.36 M(+7.6%) |
| June 2022 | - | $2.19 M(-13.1%) |
| Mar 2022 | - | $2.52 M(+41.1%) |
| Dec 2021 | $1.79 M(-9.1%) | $1.79 M(-2.0%) |
| Sept 2021 | - | $1.82 M(+10.1%) |
| June 2021 | - | $1.66 M(+46.7%) |
| Mar 2021 | - | $1.13 M(-42.5%) |
| Dec 2020 | $1.97 M(-3.6%) | $1.97 M(+3.6%) |
| Sept 2020 | - | $1.90 M(-6.0%) |
| June 2020 | - | $2.02 M(+11.7%) |
| Mar 2020 | - | $1.81 M(-11.4%) |
| Dec 2019 | $2.04 M(+89.8%) | $2.04 M(+22.5%) |
| Sept 2019 | - | $1.66 M(-2.8%) |
| June 2019 | - | $1.71 M(+19.8%) |
| Mar 2019 | - | $1.43 M(+33.1%) |
| Dec 2018 | $1.07 M(-51.8%) | $1.07 M(+26.5%) |
| Sept 2018 | - | $849.00 K(-47.4%) |
| June 2018 | - | $1.61 M(-19.2%) |
| Mar 2018 | - | $2.00 M(-10.4%) |
| Dec 2017 | $2.23 M(-3.0%) | $2.23 M(+24.3%) |
| Sept 2017 | - | $1.79 M(-26.6%) |
| June 2017 | - | $2.44 M(+27.7%) |
| Mar 2017 | - | $1.91 M(-16.8%) |
| Dec 2016 | $2.30 M(-25.0%) | $2.30 M(+30.6%) |
| Sept 2016 | - | $1.76 M(+31.9%) |
| June 2016 | - | $1.33 M(+3.1%) |
| Mar 2016 | - | $1.29 M(-57.8%) |
| Dec 2015 | $3.06 M(-31.7%) | $3.06 M(+18.1%) |
| Sept 2015 | - | $2.59 M(+26.9%) |
| June 2015 | - | $2.04 M(-1.7%) |
| Mar 2015 | - | $2.08 M(-53.6%) |
| Dec 2014 | $4.48 M(+9.0%) | $4.48 M(+0.8%) |
| Sept 2014 | - | $4.45 M(-6.5%) |
| June 2014 | - | $4.76 M(+2.4%) |
| Mar 2014 | - | $4.65 M(+13.0%) |
| Dec 2013 | $4.12 M(+12.1%) | $4.12 M(+21.7%) |
| Sept 2013 | - | $3.38 M(-15.5%) |
| June 2013 | - | $4.00 M(+1.9%) |
| Mar 2013 | - | $3.93 M(+6.9%) |
| Dec 2012 | $3.67 M(+7.1%) | $3.67 M(-0.5%) |
| Sept 2012 | - | $3.69 M(+3.6%) |
| June 2012 | - | $3.56 M(+11.0%) |
| Mar 2012 | - | $3.21 M(-6.3%) |
| Dec 2011 | $3.43 M(-34.0%) | $3.43 M(+6.4%) |
| Sept 2011 | - | $3.22 M(-0.3%) |
| June 2011 | - | $3.23 M(+0.5%) |
| Mar 2011 | - | $3.22 M(-38.1%) |
| Dec 2010 | $5.20 M | $5.20 M(+176.0%) |
| Sept 2010 | - | $1.88 M(+12.4%) |
| June 2010 | - | $1.68 M(+25.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $1.33 M(-23.6%) |
| Dec 2009 | $1.74 M(+39.4%) | $1.74 M(+24.8%) |
| Sept 2009 | - | $1.40 M(+0.7%) |
| June 2009 | - | $1.39 M(+7.8%) |
| Mar 2009 | - | $1.29 M(+2.9%) |
| Dec 2008 | $1.25 M(-2.2%) | $1.25 M(-15.6%) |
| Sept 2008 | - | $1.48 M(-2.3%) |
| June 2008 | - | $1.52 M(+10.0%) |
| Mar 2008 | - | $1.38 M(+7.9%) |
| Dec 2007 | $1.28 M(-39.5%) | $1.28 M(+20.0%) |
| Sept 2007 | - | $1.07 M(+11.4%) |
| June 2007 | - | $956.20 K(-41.2%) |
| Mar 2007 | - | $1.63 M(-23.1%) |
| Dec 2006 | $2.12 M(-14.1%) | $2.12 M(-2.6%) |
| Sept 2006 | - | $2.17 M(+25.1%) |
| June 2006 | - | $1.74 M(-33.2%) |
| Mar 2006 | - | $2.60 M(+5.5%) |
| Dec 2005 | $2.46 M(+19.9%) | $2.46 M(+12.5%) |
| Sept 2005 | - | $2.19 M(+6.0%) |
| June 2005 | - | $2.06 M(-2.6%) |
| Mar 2005 | - | $2.12 M(+3.2%) |
| Dec 2004 | $2.05 M(+19.1%) | $2.05 M(+11.4%) |
| Sept 2004 | - | $1.84 M(-12.7%) |
| June 2004 | - | $2.11 M(+48.5%) |
| Mar 2004 | - | $1.42 M(-17.5%) |
| Dec 2003 | $1.72 M(+17.2%) | $1.72 M(+25.7%) |
| Sept 2003 | - | $1.37 M(+50.9%) |
| June 2003 | - | $908.90 K(+10.2%) |
| Mar 2003 | - | $824.40 K(-44.0%) |
| Dec 2002 | $1.47 M(+96.9%) | $1.47 M(+62.5%) |
| Sept 2002 | - | $905.50 K(-13.6%) |
| June 2002 | - | $1.05 M(-2.8%) |
| Mar 2002 | - | $1.08 M(+44.2%) |
| Dec 2001 | $747.50 K(+130.9%) | $747.50 K(+5.4%) |
| Sept 2001 | - | $709.30 K(-6.5%) |
| June 2001 | - | $758.40 K(+287.1%) |
| Mar 2001 | - | $195.90 K(-39.5%) |
| Dec 2000 | $323.80 K(-61.1%) | $323.80 K(+17.1%) |
| Sept 2000 | - | $276.40 K(-46.1%) |
| June 2000 | - | $512.70 K(-15.1%) |
| Mar 2000 | - | $604.10 K(-27.5%) |
| Dec 1999 | $833.30 K(+176.8%) | $833.30 K(+317.1%) |
| Sept 1999 | - | $199.80 K(>+9900.0%) |
| June 1999 | - | $0.00(-100.0%) |
| Mar 1999 | - | $200.10 K(-33.5%) |
| Dec 1998 | $301.00 K(+50.7%) | $301.00 K(+200.4%) |
| Sept 1998 | - | $100.20 K(+0.1%) |
| June 1998 | - | $100.10 K(+0.2%) |
| Mar 1998 | - | $99.90 K(-50.0%) |
| Dec 1997 | $199.80 K | $199.80 K(+99.8%) |
| Sept 1997 | - | $100.00 K(-50.0%) |
| June 1997 | - | $200.00 K |
FAQ
- What is Nymox Pharmaceutical annual total current liabilities?
- What is the all time high annual current liabilities for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual total current liabilities?
The current annual current liabilities of NYMX is $2.11 M
What is the all time high annual current liabilities for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual total current liabilities is $5.20 M
What is Nymox Pharmaceutical quarterly total current liabilities?
The current quarterly current liabilities of NYMX is $2.37 M
What is the all time high quarterly current liabilities for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly total current liabilities is $5.20 M